Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: June 8, 2023

Investigational Drug Information for NNZ-2591

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the development status for investigational drug NNZ-2591?

NNZ-2591 is an investigational drug.

There have been 13 clinical trials for NNZ-2591. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1^st 2014.

The most common disease conditions in clinical trials are Syndrome, Brain Injuries, Traumatic, and Brain Injuries. The leading clinical trial sponsors are Neuren Pharmaceuticals Limited, Baylor College of Medicine, and International Rett Syndrome Foundation.

Summary for NNZ-2591

US Patents	0
International Patents	0
US Patent Applications	11
WIPO Patent Applications	7
Japanese Patent Applications	0
Clinical Trial Progress	Phase 2 (2014-01-01)
Vendors	5

Recent Clinical Trials for NNZ-2591

Title	Sponsor	Phase
An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)	Neuren Pharmaceuticals Limited	Phase 2
An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome	Neuren Pharmaceuticals Limited	Phase 2
An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)	Neuren Pharmaceuticals Limited	Phase 2

See all NNZ-2591 clinical trials

Clinical Trial Summary for NNZ-2591

Top disease conditions for NNZ-2591

Top clinical trial sponsors for NNZ-2591

See all NNZ-2591 clinical trials

US Patents for NNZ-2591

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Merck

Dow

AstraZeneca

Medtronic

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.